Get started
Avita Medical, Inc.Avita Medical, Inc.Avita Medical, Inc.

Avita Medical, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RCEL chart


Full chart

RCEL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪338.47 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.23 USD
Net income (FY)
‪−35.38 M‬ USD
Revenue (FY)
‪50.14 M‬ USD
Shares float
‪24.63 M‬
Beta (1Y)
2.29

Employees


Employees (FY)
207
Change (1Y)
+81 +64.29%
Revenue / Employee (1Y)
‪242.24 K‬ USD
Net income / Employee (1Y)
‪−170.92 K‬ USD

About Avita Medical, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
James M. Corbett
Website
avitamedical.com
Headquarters
Valencia
Founded
2020
FIGI
BBG00TD18T43
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RCEL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RCEL is 12.91 USD — it has increased by 9.87% in the past 24 hours. Watch Avita Medical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avita Medical, Inc. stocks are traded under the ticker RCEL.
RCEL stock has risen by 4.03% compared to the previous week, the month change is a 0.62% rise, over the last year Avita Medical, Inc. has showed a 0.86% increase.
We've gathered analysts' opinions on Avita Medical, Inc. future price: according to them, RCEL price has a max estimate of 26.00 USD and a min estimate of 10.56 USD. Watch RCEL chart and read a more detailed Avita Medical, Inc. stock forecast: see what analysts think of Avita Medical, Inc. and suggest that you do with its stocks.
RCEL reached its all-time high on Feb 19, 2020 with the price of 55.35 USD, and its all-time low was 3.75 USD and was reached on Nov 20, 2017. View more price dynamics on RCEL chart.
See other stocks reaching their highest and lowest prices.
RCEL stock is 12.87% volatile and has beta coefficient of 2.29. Track Avita Medical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Avita Medical, Inc. there?
Today Avita Medical, Inc. has the market capitalization of ‪320.72 M‬, it has decreased by −6.15% over the last week.
Yes, you can track Avita Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Avita Medical, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
RCEL earnings for the last quarter are −0.62 USD per share, whereas the estimation was −0.43 USD resulting in a −42.76% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Avita Medical, Inc. earnings.
Avita Medical, Inc. revenue for the last quarter amounts to ‪19.55 M‬ USD, despite the estimated figure of ‪19.44 M‬ USD. In the next quarter, revenue is expected to reach ‪23.17 M‬ USD.
RCEL net income for the last quarter is ‪−16.20 M‬ USD, while the quarter before that showed ‪−15.39 M‬ USD of net income which accounts for −5.28% change. Track more Avita Medical, Inc. financial stats to get the full picture.
No, RCEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 207.00 employees. See our rating of the largest employees — is Avita Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avita Medical, Inc. EBITDA is ‪−136.78 M‬ USD, and current EBITDA margin is −241.99%. See more stats in Avita Medical, Inc. financial statements.
Like other stocks, RCEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avita Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avita Medical, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avita Medical, Inc. stock shows the buy signal. See more of Avita Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.